Royalty Pharma Names Kenneth Sun as Senior Vice President and Head of Asia, Strengthening Its Global Expansion Strategy and Regional Presence Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Kenneth Sun as Senior Vice President and Head of…
Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening Wisdom Bioscience, a biotechnology company revolutionizing oral cancer diagnostics, has announced the formation of its Scientific Advisory Board (SAB) following a successful initial funding round. The SAB…
Roche’s fenebrutinib reaffirms potential as the sole BTK inhibitor for relapsing and primary progressive MS with positive FENhance 1 Phase III results. Roche announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its primary…
Poplar Therapeutics Closes $45 million Series A Extension to Advance Development of Lead Program, PHB-050, A New Class of Anti-IgE Therapy for Multiple Atopic Conditions Extension financing adds new investors, Janus Henderson Investors and RA Capital, with strong renewed participation…
Acadia Pharmaceuticals Reports Strong Fourth Quarter and Record Full-Year 2025 Financial Results, Highlights Pipeline Progress and Strategic Expansion Acadia Pharmaceuticals Inc today announced its financial results for the fourth quarter and full-year ended December 31, 2025, marking a milestone year…
BioTalent Canada Breaks Barriers in Opening Applications for 2026 I.D.E.A.L. Scholarship™ BioTalent Canada has opened applications for the third annual I.D.E.A.L. Scholarship which will close on June 8, 2026. Full details and application forms available on BioTalent Canada’s website.Breaking down financial…
Sarepta Therapeutics Reports Strong Financial Performance and Advances in Gene and RNA Therapies for Rare Diseases in 2025 Sarepta Therapeutics, Inc., a recognized leader in precision genetic medicine for rare diseases, today reported its financial results for the fourth quarter…
Sun Nuclear Introduces Daily QA 4 Pro to Enhance Machine Quality Assurance in Cancer Care Why is the future of cancer care quality and patient safety becoming increasingly critical for medical physicists and radiation therapy professionals? Sun Nuclear, a Mirion…
Montrose Environmental Group Reports Record 2025 Performance and Strong Outlook for 2026 Montrose Environmental Group, Inc., a leading provider of environmental services committed to protecting air, water, and soil while promoting sustainable economic growth, today announced its financial results for…
New Combination Therapy Demonstrates 47% Reduction in Event-Free Survival Events Why is this a game-changer for bladder cancer treatment? Merck, a global leader in healthcare, has announced groundbreaking results from the Phase 3 KEYNOTE-B15 trial, which demonstrated that the combination of…